IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q1 2017 Holdings

Filed 2017-05-15 | 17 holdings | $4.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anavex Life Sciences Corp(AVXL)COM NEW032797300$4.2M724,20585.9%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$620.0K124,09612.8%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$30.8K3,738,9250.6%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$11.7K2,359,7670.2%
Vascular Biogenics LTDCOMM96883109$4.7K860,6050.1%
Newlink Genetics CorpCOM651511107$2.3K93,5330.0%
Ampio Pharmaceuticals Inc.COM03209T109$2.2K2,738,3220.0%
Volition RX LTD(VNRX)COM928661107$1.9K461,5380.0%
Alcobra LtdSHSM2239P109$1.4K1,205,4980.0%
Summit Therapeutics PLCSPONS ADS86627R102$1.3K100,0000.0%
Keryx Biopharmaceuticals Inc.COM492515101$1.2K200,0000.0%
Ritter Pharmaceuticals, IncCOM767836109$1.1K802,4340.0%
Neurotrope IncCOM NEW64129T207$86745,3880.0%
Caladrius Biosciences Inc(NBSEUR)COM NEW128058203$593117,9570.0%
Evoke Pharma IncCOM30049G104$543175,0000.0%
Advaxis Inc.W EXP 07/15/201007624117$500112,5000.0%
Amicus Therapeutics Inc.(FOLD)COM03152W109$35750,0000.0%